T
Thomas A. Pearson
Researcher at University of Florida
Publications - 359
Citations - 43698
Thomas A. Pearson is an academic researcher from University of Florida. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 84, co-authored 349 publications receiving 41573 citations. Previous affiliations of Thomas A. Pearson include University of Rochester & Columbia University.
Papers
More filters
Journal ArticleDOI
Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association
Thomas A. Pearson,George A. Mensah,R. Wayne Alexander,Jeffrey L. Anderson,Richard O. Cannon,Michael H. Criqui,Yazid Y. Fadl,Stephen P. Fortmann,Yuling Hong,Gary L. Myers,Nader Rifai,Sidney C. Smith,Kathryn A. Taubert,Russell P. Tracy,Frank Vinicor +14 more
TL;DR: There has been no consensus from professional societies or governmental agencies as to how these assays of markers of inflammation should be used in clinical practice, and a workshop to address these issues was convened in Atlanta, Ga.
Journal ArticleDOI
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Deepak L. Bhatt,Keith A.A. Fox,Werner Hacke,Peter B. Berger,Henry R. Black,William E. Boden,Patrice Cacoub,Eric A. Cohen,Mark A. Creager,J. Donald Easton,Marcus Flather,Steven M. Haffner,Christian W. Hamm,Graeme J. Hankey,S. Claiborne Johnston,Koon Hou Mak,Jean-Louis Mas,Gilles Montalescot,Thomas A. Pearson,P. Gabriel Steg,Steven R. Steinhubl,Michael A. Weber,Danielle M. Brennan,Liz Fabry-Ribaudo,Joan E. Booth,Eric J. Topol +25 more
TL;DR: In this article, the authors compared the effect of clopidogrel and low-dose aspirin on the rate of myocardial infarction, stroke, or death from cardiovascular causes.
Journal ArticleDOI
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Larry B. Goldstein,Cheryl Bushnell,Robert J. Adams,Lawrence J. Appel,Lynne T. Braun,Seemant Chaturvedi,Mark A. Creager,Antonio Culebras,Robert H. Eckel,Robert G. Hart,Judith A. Hinchey,Virginia J. Howard,Edward C. Jauch,Steven R. Levine,James F. Meschia,Wesley S. Moore,J.V. (Ian) Nixon,Thomas A. Pearson +17 more
TL;DR: Evidence-based recommendations are included for the control of risk factors, interventional approaches to atherosclerotic disease of the cervicocephalic circulation, and antithrombotic treatments for preventing thrombosis and thromboembolic stroke.
Journal ArticleDOI
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update Endorsed by the National Heart, Lung, and Blood Institute
Sidney C. Smith,Jerilyn K. Allen,Steven N. Blair,Robert O. Bonow,Lawrence M. Brass,Gregg C. Fonarow,Scott M. Grundy,Loren F. Hiratzka,Daniel W. Jones,Harlan M. Krumholz,Lori Mosca,Richard C. Pasternak,Thomas A. Pearson,Marc A. Pfeffer,Kathryn A. Taubert +14 more
TL;DR: The development of the present statement involved a process of partial adaptation of other guideline statements and reports and supplemental literature searches, which confirmed that aggressive comprehensive risk factor management improves survival, reduces recurrent events and the need for interventional procedures, and improves quality of life for patients with established coronary disease.
Journal ArticleDOI
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases
Thomas A. Pearson,Steven N. Blair,Stephen R. Daniels,Robert H. Eckel,Joan M. Fair,Stephen P. Fortmann,Barry A. Franklin,Larry B. Goldstein,Philip Greenland,Scott M. Grundy,Yuling Hong,Nancy Houston Miller,Ronald M. Lauer,Ira S. Ockene,Ralph L. Sacco,James F. Sallis,Sidney C. Smith,Neil J. Stone,Kathryn A. Taubert +18 more
TL;DR: This 2002 update of the Guide acknowledges a number of advances in the field of primary prevention since 1997 and research continues to refine the recommendations on detection and management of established risk factors.